Research Reports

Total organic sales growth of 2.8%; acquisitions added 3.2%; FX added 1.5% for total sales growth of 7.5% (CFO)
Americas & Asia organic sales growth of 4.7%; segment profit up 9% to $59.9M; segment margin 22.3% (CEO, CFO)
Europe & Australia organic sales declined 0.8%; segment profit up 42.8% to $18.7M; segment margin 13.7% (CEO, CFO)
Gross profit margin 51.5% vs 50.3% prior year; excluding acquisition-related adjustment, gross margin was 51.4% last year (CFO)
SG&A $117.6M (29% of sales) vs $111.8M (29.7% of sales) prior year; adjusted SG&A 27.7% of sales vs 28.3% (CFO)
R&D expense $23.3M (5.7% of sales), up 23% from $18.9M (5% of sales) prior year (CFO)
Operating cash flow $33.4M, up 42.5%; free cash flow $22.4M, up 38.8% (CFO)
Net cash position of $66.8M at Oct 31 (CFO)
Repurchased 55,000 shares for $4.1M at avg $73.69/share in Q1 (CFO)
Tariff headwind: full-year impact now projected at ~$8M (low end of prior $8M–$12M range) (CEO)
Wire ID product line grew nearly 19% in Americas & Asia; data centers a key end market (CEO)
Asia organic sales growth 11.9%; Japan led; China grew 0.8%; Asia outside China grew nearly 20% (CEO)

Official Guidance (CFO):

FY2026 adjusted diluted EPS: $4.90–$5.15 (raised bottom end by $0.05); represents 6.5%–12% growth over FY2025
FY2026 GAAP diluted EPS: $4.57–$4.82 (raised bottom end by $0.05)
FY2026 organic sales growth: low single-digit percentages
FY2026 income tax rate: ~21%
FY2026 D&A: ~$44M
FY2026 CapEx: ~$40M

Mgmt Quotes:

“We had a good start to the year with organic sales growth of 2.8% and adjusted earnings per share growth of 8%.” (CEO)
“Our gross profit margin continues to be strong as we realize the benefits from our sales growth coming from our engineered products.” (CFO)
“We funded a 23% increase in R&D in the quarter and still grew the bottom line.” (CFO)
“We are experiencing a tariff headwind in the U.S. compared to last year’s Q1… we are now projecting full year impact to be at the low end of this range, so approximately $8 million.” (CEO)
“We started the year with some solid momentum. We’re growing organic sales mid-single digits in America and Asia, and we’re nearly returned to growth in Europe and Australia.” (CEO)

Metric	Value	Speaker/Context
Total organic sales growth	2.8%	CFO
Americas & Asia organic sales growth	4.7%	CEO
Europe & Australia organic sales growth	(0.8%)	CEO
Gross profit margin	51.5%	CFO
Adjusted SG&A as % of sales	27.7%	CFO
R&D as % of sales	5.7%	CFO
Operating cash flow	$33.4M	CFO
Free cash flow	$22.4M	CFO
Net cash position	$66.8M	CFO
Americas & Asia segment profit	$59.9M	CEO
Europe & Australia segment profit	$18.7M	CEO
FY2026 adjusted diluted EPS guidance	$4.90–$5.15	CFO
FY2026 CapEx guidance	~$40M	CFO

Topic: Gross margin drivers, R&D run rate, cost-out benefits, cash conversion, inventory
Key points:
- Gross margin strength driven by price actions and supply chain reconfiguration (moving production/sourcing across countries); tariff impact projected at $8M–$12M, trending toward low end of range, contributing to raising guidance bottom end by $0.05.
- R&D at 5%–7% due to acquisitions; expected to streamline to ~5.5% over next few quarters; no specific target but directionally 5.5% for next year.
- Cost-out actions (plant consolidation, workforce reductions) ~80% complete in Q1; no additional restructuring charges anticipated.
- Cash conversion improvement in Q1 is expected to normalize toward 100% for the year; inventory elevated due to acquisitions, stocking high-running products, and moving printer lines in Asia; inventory likely not to increase much further.
Mgmt stance: Neutral – gross margin benefits from active management but offset by tariffs; R&D streamlining minor; cost-out largely done; cash conversion target reasonable; inventory normalization expected.

Topic: Europe/Australia segment outlook, BradyScan launch, acquisition synergies, gross margin trajectory
Key points:
- Europe/Australia segment saw slight decline in Q1; guidance for low single-digit growth by year-end based on economist forecasts for calendar 2026 improvement; core manufacturing in Germany, France, UK not improving; turnaround expected 1–2 quarters out.
- BradyScan app launched with consumer free version (50 scans/month) and industrial version for connected products (printers, readers); next step to integrate with lasers and marking tech; ~50% complete; only 5-star reviews as of weekend.
- Gravotech and Mecco acquisitions: product roadmap completed; heavy industrial manufacturing (key end market) is weakest segment; automotive supply chain weak; confident in long-term thesis that everything will be marked in production.
- Gross margins: engineered products ~60% gross margin, commodity products ~40%; portfolio shift helps but tariffs offset; no target; prefers growth over margin expansion to drive cash flow.
Mgmt stance: Neutral – Europe/Australia macro still weak, no green shoots; BradyScan early but positive reception; acquisitions facing tough environment but long-term confident; gross margin improvement possible but not prioritized over growth.